[NIH SACGHS Webcasts]
[20 Oct 2005]
[19 Oct 2005]
[16 June 2005]
[15 June 2005]
[1 Mar 2005]
[28 Feb 2005]
[19 Oct 2004]
[18 Oct 2004]
[2 March 2004]
[1 March 2004]
[15june2004]
[14june2004]
[12 June 2003]
[11 June 2003]
[23 Oct 2003]
[22 Oct 2003]

National Institutes of Health

Secretary’s Advisory Committee on Genetics, Health, and Society

Seventh Meeting

June 16, 2005

North Bethesda , MD

CAPTION TEXT (HTML)
NOTE: The caption text is a record of the close captioning offered to support the video. It is not a totally accurate, verbatim transcript of the meeting. It is offered here for interest and support of the video. A correct transcript will be available on the NIH web site in due course.

Morning Session before Break (Real Video)

Morning Session after Break  (Real Video)

Afternoon Session before Break  (Real Video)

Afternoon Session after Break  (Real Video)

A G E N D A

(To view the Agenda in PDF format, click here.)

Thursday, June 16, 2005

8:30 a.m. – 5:00 p.m. Current Issues in Pharmacogenomics

8:30 – 8:40 Session Overview and Goals  (Real Video)
Emily Winn-Deen, Ph.D.
Chair, SACGHS Pharmacogenomics Task Force

8:40 – 9:00 Fundamentals of Pharmacogenomics: Origins, Definitions and Concepts (Real Video)

Richard M. Weinshilboum, M.D.
Professor of Molecular Pharmacology and Experimental Therapeutics and Medicine
Mayo Clinic College of Medicine

9:00 – 9:15 Q&A and Discussion  (Real Video)

9:15 – 9:45 Pharmacogenomics: The Public Health Perspective  (Real Video)

Robert L. Davis, M.D., M.P.H.
Professor, Department of Epidemiology
University of Washington School of Public Health

9:45 – 10:05  Q & A and Discussion   (Real Video)

10:05 – 10:20 BREAK

10:20 – 10:50   Pharmacogenomics in the Practice of Medicine  (Real Video)

Dr. Weinshilboum

10:50 – 11:10  Q&A and Discussion  (Real Video)

11:10 – 11:40 Perspectives from Industry  (Real Video)

Eric Lai, Ph.D.
Vice President
Discovery and Pipeline Genetics
GlaxoSmithKline

Walter Koch, Ph.D.
Vice President and Head of Research
Roche Molecular Systems

11:40 – 12:00  Q&A and Discussion   (Real Video)

12:00 – 12:30  Public Comments   (Real Video)

12:30 – 1:30    LUNCH

1:30 – 2:00 HHS Efforts and Future Directions in Pharmacogenomics

Rochelle Long, Ph.D.  (Real Video)
Chief, Pharmacological & Physiological Sciences Branch
National Institute of General Medical Sciences, NIH

Felix Frueh, Ph.D.  (Real Video)
Associate Director for Genomics
Office of Clinical Pharmacology and Biopharmaceutics
Center for Drug Evaluation and Research, FDA

Muin Khoury, M.D., Ph.D.  (Real Video)
Director
Office of Genomics and Disease Prevention, CDC

2:00 – 2:20 Q&A and Discussion   (Real Video)

2:20 – 2:45 Ethical, Legal and Social Implications of Pharmacogenomics  (Real Video)

Patricia Deverka, M.D., M.S., M.B.E.
Fellow at Center for Genome Ethics, Law & Policy
Institute for Genome Sciences & Policy
Duke University

2:45 – 3:05  Q&A and Discussion   (Real Video)

3:05 – 3:15  BREAK

3:15 – 4:30  Full Committee Discussion and Next Steps for Pharmacogenomics  (Real Video)

Facilitators: Dr. Willard and Dr. Winn-Deen

4:30 – 5:00   Next Steps and Closing Remarks  (Real Video)

ADJOURN